CC

Did you buy CC securities between February 20, 2026 and August 4, 2026? Affected CC Investor Summary Who: The Chemours Company (NYSE: CC) What: Securities fraud class action lawsuit filed Class Period: February 20, 2026 through August 4, 2026 Deadline to Seek Lead Plaintiff Status: December 7, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the reliability of the company's financial guidance Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa.

LOS ANGELES, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

New York, New York--(Newsfile Corp. - October 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours" or the "Company") (NYSE: CC) on behalf of investors that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Chemours and have suffered losses, you may CLICK HERE to contact us.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Chemours, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/chemours-class-action-lawsuit.

SAN DIEGO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products for markets including, as relevant here, refrigeration and air conditioning.

NEW ORLEANS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC), if they purchased or otherwise acquired The Chemours Company securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the Class Period). Investors who purchased Chemours shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for December 7, 2026.

Notice to Pension Funds, Asset Managers, and Fiduciaries: The lawsuit alleges Chemours overstated aftermarket demand for its Opteon refrigerants and reaffirmed 2026 guidance that did not account for sales pulled forward by 2025 distributor stocking. NEW YORK, Oct. 15, 2026 /PRNewswire/ -- SueWallSt notifies pension funds, asset managers, and other institutional investors in The Chemours Company (NYSE: CC) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between February 20, 2026 and August 4, 2026, before an 18.63% single-session decline in CC shares.

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Chemours Company ("Chemours " or the "Company") (NYSE: CC) and certain officers. The class action, filed in the United States District Court for the District of Delaware, and docketed under 26-cv-01299, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Chemours securities between February 20, 2026 and August 4, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - October 15, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (""The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.